217 related articles for article (PubMed ID: 23148179)
1. Current concepts in graves' disease.
Girgis CM; Champion BL; Wall JR
Ther Adv Endocrinol Metab; 2011 Jun; 2(3):135-44. PubMed ID: 23148179
[TBL] [Abstract][Full Text] [Related]
2. 2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism.
Kahaly GJ; Bartalena L; Hegedüs L; Leenhardt L; Poppe K; Pearce SH
Eur Thyroid J; 2018 Aug; 7(4):167-186. PubMed ID: 30283735
[TBL] [Abstract][Full Text] [Related]
3. A review of treatment options for Graves' disease: why total thyroidectomy is a viable option in selected patients.
Mohan V; Lind R
J Community Hosp Intern Med Perspect; 2016; 6(4):32369. PubMed ID: 27609732
[TBL] [Abstract][Full Text] [Related]
4. Management of Graves' hyperthyroidism: present and future.
Bartalena L; Piantanida E; Gallo D; Ippolito S; Tanda ML
Expert Rev Endocrinol Metab; 2022 Mar; 17(2):153-166. PubMed ID: 35287535
[TBL] [Abstract][Full Text] [Related]
5. Graves' Disease Pharmacotherapy in Women of Reproductive Age.
Prunty JJ; Heise CD; Chaffin DG
Pharmacotherapy; 2016 Jan; 36(1):64-83. PubMed ID: 26799350
[TBL] [Abstract][Full Text] [Related]
6. Current concepts regarding Graves' orbitopathy.
Bartalena L; Tanda ML
J Intern Med; 2022 Nov; 292(5):692-716. PubMed ID: 35604323
[TBL] [Abstract][Full Text] [Related]
7. Selenium supplementation for patients with Graves' hyperthyroidism (the GRASS trial): study protocol for a randomized controlled trial.
Watt T; Cramon P; Bjorner JB; Bonnema SJ; Feldt-Rasmussen U; Gluud C; Gram J; Hansen JL; Hegedüs L; Knudsen N; Bach-Mortensen P; Nolsøe R; Nygaard B; Pociot F; Skoog M; Winkel P; Rasmussen AK
Trials; 2013 Apr; 14():119. PubMed ID: 23782950
[TBL] [Abstract][Full Text] [Related]
8. Thyroid surgery for treatment of Graves' disease complicated by ophthalmopathy: a comprehensive review.
Wong J; Wiseman SM
Expert Rev Endocrinol Metab; 2015 May; 10(3):327-336. PubMed ID: 30298775
[TBL] [Abstract][Full Text] [Related]
9. Graves' disease in children.
Léger J; Oliver I; Rodrigue D; Lambert AS; Coutant R
Ann Endocrinol (Paris); 2018 Dec; 79(6):647-655. PubMed ID: 30180972
[TBL] [Abstract][Full Text] [Related]
10. Treatment of patients with Graves' disease and the appropriate extent of thyroidectomy.
Bobanga ID; McHenry CR
Best Pract Res Clin Endocrinol Metab; 2019 Aug; 33(4):101319. PubMed ID: 31530446
[TBL] [Abstract][Full Text] [Related]
11. Recurrent Graves' Disease Following Near-Total Thyroidectomy: A Case Report and Literature Review.
Menon LP; Naqvi S; Maradana J; Edem D
Cureus; 2024 Jan; 16(1):e52260. PubMed ID: 38352081
[TBL] [Abstract][Full Text] [Related]
12. Non-thionamide antithyroid drug options in Graves' hyperthyroidism.
Ruslan A; Okosieme OE
Expert Rev Endocrinol Metab; 2023 Jan; 18(1):67-79. PubMed ID: 36740774
[TBL] [Abstract][Full Text] [Related]
13. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
[TBL] [Abstract][Full Text] [Related]
14. Thyroid-Stimulating Hormone Receptor Antibodies in Pregnancy: Clinical Relevance.
Bucci I; Giuliani C; Napolitano G
Front Endocrinol (Lausanne); 2017; 8():137. PubMed ID: 28713331
[TBL] [Abstract][Full Text] [Related]
15. Graves' Disease that Developed Shortly after Surgery for Thyroid Cancer.
Yu HM; Park SH; Lee JM; Park KS
Endocrinol Metab (Seoul); 2013 Sep; 28(3):226-30. PubMed ID: 24396683
[TBL] [Abstract][Full Text] [Related]
16. Thyroid Receptor Antibody and the Development of Graves' Orbitopathy: Clinical Experience of using Radioiodine Ablation in the Management of Graves' Orbitopathy in post-iodine ablation hypothyroid patient.
Christina E; Budiawan H; Indrawati H; Affandi Soeriadi E; Nugrahadi T; Kartamihardja AH
Asia Ocean J Nucl Med Biol; 2023; 11(2):185-190. PubMed ID: 37324233
[TBL] [Abstract][Full Text] [Related]
17. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
Hancock LD; Tuttle RM; LeMar H; Bauman J; Patience T
Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcome of Graves' disease in Thai children.
Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
[TBL] [Abstract][Full Text] [Related]
19. Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy.
Laurberg P; Bournaud C; Karmisholt J; Orgiazzi J
Eur J Endocrinol; 2009 Jan; 160(1):1-8. PubMed ID: 18849306
[TBL] [Abstract][Full Text] [Related]
20. Management of recurrent hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.
Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
J Endocrinol Invest; 1995 Jun; 18(6):415-9. PubMed ID: 7594234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
